Hogere bloed-seleniumspiegels gekoppeld aan lagere sterfte bij CKM-syndroom — NHANES-cohort
In een prospectief cohort van 6.072 NHANES-deelnemers met het cardiorenale-metabole (CKM)-syndroom bleek een hogere bloed-seleniumspiegel geassocieerd met een 38% lager sterfterisico (HR 0,62; 95% BI 0,45–0,85; p=0,003) vergeleken met de laagste kwartiel. De dosis-responsrelatie volgde een L-vormig patroon en dit effect was consistent in zowel vroege als gevorderde CKM-stadia. Mediatie-analyse suggereert dat systemische ontsteking (gemeten via NLR, MLR en SIRI) een kleine rol speelt in dit verband. Hoewel observatief, benadrukt het onderzoek de potentiële waarde van seleniumstatus en ontstekingsremmende strategieën in de zorg voor deze kwetsbare patiëntengroep.
Abstract (original)
Cardiovascular-kidney-metabolic (CKM) syndrome, characterized by the pathophysiological interplay among metabolic disorders, chronic kidney disease (CKD), and cardiovascular disease (CVD), significantly elevates mortality risk. Environmental heavy metal exposure and selenium deficiency are implicated in these conditions, but their combined impact on CKM syndrome is unclear. To investigate the associations of blood heavy metals (lead [Pb], cadmium [Cd], mercury [Hg], manganese [Mn]) and selenium (Se) with all-cause mortality in CKM populations, and examine the mediating role of inflammatory biomarkers. This cross-sectional study with prospective mortality follow-up included 6,072 participants from NHANES (2011-2018). Kaplan-Meier curves, multivariable Cox regression models, and restricted cubic spline (RCS) analyses were employed to assess all-cause mortality associations. Subgroup and interaction analyses evaluated risks across demographic strata. Mediation analysis was employed to explore the mediating effects of inflammatory biomarkers (NLR, MLR, NMLR, and SIRI). The Weighted quantile sum (WQS) model was utilized to estimate the effects of combined blood metal exposures. Among 6,072 participants, 409 deaths occurred during follow-up. In the fully adjusted model, there was a significant negative correlation between blood selenium levels and all-cause mortality in the CKM population. Compared with the lowest quartile (Q1), the highest selenium quartile (Q4) was associated with a 38% reduced mortality risk (HR = 0.62, 95% CI: 0.45-0.85, P = 0.003). RCS analysis revealed an L-shaped dose-response relationship (P for nonlinear = 0.002). Subgroup analyses confirmed consistent associations in both non-advanced CKM (stages 0-2) and advanced CKM (stages 3-4) (all P < 0.05, P for interaction = 0.163). Mediation analysis revealed that NLR, MLR, NMLR, and SIRI partially mediated the association between blood selenium and all-cause mortality, and the mediated proportions were relatively modest (ranging from 3.57 to 5.29%). Higher blood selenium was associated with reduced all-cause mortality in CKM syndrome after adjustment for measured confounders, and mediation analysis suggested a potential partial role of inflammation in this association. These findings underscore the need for targeted interventions to mitigate mortality in this high-risk population.
Dit artikel is een samenvatting van een publicatie in Cardiovascular toxicology. Voor het volledige artikel, alle details en referenties verwijzen wij u naar de oorspronkelijke bron.
Lees het volledige artikelDOI: 10.1007/s12012-026-10179-8
Wilt u op de hoogte blijven?
Gratis: de maandelijkse nieuwsbrief met het nieuwsoverzicht, en de site afgestemd op uw vakgebied.


